Cargando…
O-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease
O-Linked β-N-acetyl glucosaminylation (O-GlcNAcylation) is a dynamic post-translational modification that occurs on serine and threonine residues of cytosolic and nuclear proteins in all cell types, including those involved in the cardiovascular system. O-GlcNAcylation is thought to act in a manner...
Autores principales: | Karunakaran, Udayakumar, Jeoung, Nam Ho |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932889/ https://www.ncbi.nlm.nih.gov/pubmed/20835337 http://dx.doi.org/10.4093/kdj.2010.34.4.211 |
Ejemplares similares
-
O-GlcNAc Modification and Its Role in Diabetic Retinopathy
por: Liu, Chengzhi, et al.
Publicado: (2022) -
The potential role of O-GlcNAc modification in cancer epigenetics
por: Forma, Ewa, et al.
Publicado: (2014) -
X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body
por: Olivier-Van Stichelen, Stéphanie, et al.
Publicado: (2014) -
Feedback Regulation of O-GlcNAc Transferase through Translation Control to Maintain Intracellular O-GlcNAc Homeostasis
por: Lin, Chia-Hung, et al.
Publicado: (2021) -
O-GlcNAc modification: why so intimately associated with phosphorylation?
por: Mishra, Suresh, et al.
Publicado: (2011)